{"id":28978,"date":"2026-09-28T12:47:43","date_gmt":"2026-09-28T12:47:43","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/be-fr\/?page_id=28978"},"modified":"2026-09-28T12:50:42","modified_gmt":"2026-09-28T12:50:42","slug":"declaration-informations-non-financieres","status":"publish","type":"page","link":"https:\/\/www.neuraxpharm.com\/be-fr\/declaration-informations-non-financieres","title":{"rendered":"Declaration informations non financieres"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"28978\" class=\"elementor elementor-28978\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-8d35a2d elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"8d35a2d\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-c660830\" data-id=\"c660830\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-bcde9fc elementor-widget elementor-widget-text-editor\" data-id=\"bcde9fc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>(D\u00e9claration informations non financi\u00e8res &#8211; DINF, en espagnol)<\/p><p>Afin de se conformer \u00e0 la loi 11\/2018 sur l&rsquo;information non financi\u00e8re et la diversit\u00e9, Neuraxpharm Pharmaceuticals S.L.U. (anciennement Laboratorios Lesvi S.L.U.) pr\u00e9pare chaque ann\u00e9e sa d\u00e9claration d&rsquo;information non financi\u00e8re, en suivant les recommandations et les indications \u00e9tablies par la loi 11\/2018 susmentionn\u00e9e.<\/p><p>Le rapport comprend des informations sur les questions environnementales, sociales et de personnel, les droits de l&rsquo;homme, la lutte contre la corruption et les pots-de-vin, et l&rsquo;impact de l&rsquo;organisation sur la soci\u00e9t\u00e9. Pour chacune de ces questions, il d\u00e9crit les politiques et les actions mises en \u0153uvre, ainsi que les risques identifi\u00e9s et d\u00e9coulant du d\u00e9veloppement de l&rsquo;activit\u00e9 de la soci\u00e9t\u00e9. Le rapport a \u00e9t\u00e9 pr\u00e9par\u00e9 conform\u00e9ment aux principes de comparabilit\u00e9, de fiabilit\u00e9, d&rsquo;importance relative et de pertinence \u00e9nonc\u00e9s dans la loi 11\/2018 susmentionn\u00e9e.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-d3b83ef elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"d3b83ef\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-088a367\" data-id=\"088a367\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-b4eec3c elementor-align-left elementor-widget elementor-widget-button\" data-id=\"b4eec3c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/31\/2026\/09\/28124854\/informe-einf-neuraxpharm-pharmaceuticals-2023.pdf\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-download\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Rapport sur les informations non financi\u00e8res 2023<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d608f18 elementor-align-left elementor-widget elementor-widget-button\" data-id=\"d608f18\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/31\/2026\/09\/28124941\/informe-einf-laboratorios-lesvi-2022.pdf\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-download\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Rapport sur les informations non financi\u00e8res 2022<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0678b45 elementor-align-left elementor-widget elementor-widget-button\" data-id=\"0678b45\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/31\/2026\/09\/28125018\/informe-einf-laboratorios-lesvi-2021.pdf\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-download\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Rapport sur les informations non financi\u00e8res 2021<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>(D\u00e9claration informations non financi\u00e8res &#8211; DINF, en espagnol) Afin de se conformer \u00e0 la loi 11\/2018 sur l&rsquo;information non financi\u00e8re et la diversit\u00e9, Neuraxpharm Pharmaceuticals S.L.U. (anciennement Laboratorios Lesvi S.L.U.) pr\u00e9pare chaque ann\u00e9e sa d\u00e9claration d&rsquo;information non financi\u00e8re, en suivant les recommandations et les indications \u00e9tablies par la loi 11\/2018 susmentionn\u00e9e. Le rapport comprend des [&hellip;]<\/p>\n","protected":false},"author":2493,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_acf_changed":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"class_list":["post-28978","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v28.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Declaration informations non financieres - Neuraxpharm Belgique<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/be-fr\/declaration-informations-non-financieres\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Declaration informations non financieres\" \/>\n<meta property=\"og:description\" content=\"(D\u00e9claration informations non financi\u00e8res &#8211; DINF, en espagnol) Afin de se conformer \u00e0 la loi 11\/2018 sur l&rsquo;information non financi\u00e8re et la diversit\u00e9, Neuraxpharm Pharmaceuticals S.L.U. (anciennement Laboratorios Lesvi S.L.U.) pr\u00e9pare chaque ann\u00e9e sa d\u00e9claration d&rsquo;information non financi\u00e8re, en suivant les recommandations et les indications \u00e9tablies par la loi 11\/2018 susmentionn\u00e9e. Le rapport comprend des [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/be-fr\/declaration-informations-non-financieres\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm Belgique\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-28T12:50:42+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture est.\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/be-fr\\\/declaration-informations-non-financieres\",\"url\":\"https:\\\/\\\/www.neuraxpharm.com\\\/be-fr\\\/declaration-informations-non-financieres\",\"name\":\"Declaration informations non financieres - Neuraxpharm Belgique\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/be-fr\\\/#website\"},\"datePublished\":\"2026-09-28T12:47:43+00:00\",\"dateModified\":\"2026-09-28T12:50:42+00:00\",\"inLanguage\":\"fr-BE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.neuraxpharm.com\\\/be-fr\\\/declaration-informations-non-financieres\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/be-fr\\\/#website\",\"url\":\"https:\\\/\\\/www.neuraxpharm.com\\\/be-fr\\\/\",\"name\":\"Neuraxpharm Belgique\",\"description\":\"Un leader europ\u00e9en pour les produits CNS\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.neuraxpharm.com\\\/be-fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-BE\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Declaration informations non financieres - Neuraxpharm Belgique","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/be-fr\/declaration-informations-non-financieres","og_locale":"fr_FR","og_type":"article","og_title":"Declaration informations non financieres","og_description":"(D\u00e9claration informations non financi\u00e8res &#8211; DINF, en espagnol) Afin de se conformer \u00e0 la loi 11\/2018 sur l&rsquo;information non financi\u00e8re et la diversit\u00e9, Neuraxpharm Pharmaceuticals S.L.U. (anciennement Laboratorios Lesvi S.L.U.) pr\u00e9pare chaque ann\u00e9e sa d\u00e9claration d&rsquo;information non financi\u00e8re, en suivant les recommandations et les indications \u00e9tablies par la loi 11\/2018 susmentionn\u00e9e. Le rapport comprend des [&hellip;]","og_url":"https:\/\/www.neuraxpharm.com\/be-fr\/declaration-informations-non-financieres","og_site_name":"Neuraxpharm Belgique","article_modified_time":"2026-09-28T12:50:42+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture est.":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/be-fr\/declaration-informations-non-financieres","url":"https:\/\/www.neuraxpharm.com\/be-fr\/declaration-informations-non-financieres","name":"Declaration informations non financieres - Neuraxpharm Belgique","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/be-fr\/#website"},"datePublished":"2026-09-28T12:47:43+00:00","dateModified":"2026-09-28T12:50:42+00:00","inLanguage":"fr-BE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/be-fr\/declaration-informations-non-financieres"]}]},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/be-fr\/#website","url":"https:\/\/www.neuraxpharm.com\/be-fr\/","name":"Neuraxpharm Belgique","description":"Un leader europ\u00e9en pour les produits CNS","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/be-fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-BE"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/be-fr\/wp-json\/wp\/v2\/pages\/28978","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/be-fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/be-fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/be-fr\/wp-json\/wp\/v2\/users\/2493"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/be-fr\/wp-json\/wp\/v2\/comments?post=28978"}],"version-history":[{"count":5,"href":"https:\/\/www.neuraxpharm.com\/be-fr\/wp-json\/wp\/v2\/pages\/28978\/revisions"}],"predecessor-version":[{"id":28991,"href":"https:\/\/www.neuraxpharm.com\/be-fr\/wp-json\/wp\/v2\/pages\/28978\/revisions\/28991"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/be-fr\/wp-json\/wp\/v2\/media?parent=28978"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}